Ibalizumab for treating adults infected with multidrug resistant HIV-1 for whom it is not possible to construct a suppressive anti-viral regimen [ID2720]
Proposed [GID-TA10657] Expected publication date: TBC
Search results
151 results
Sorted by Relevance . | Sort by Date
- Guidance Remove Guidance filter
- Proposed Remove Proposed filter
- Technology appraisal guidance Remove Technology appraisal guidance filter
- Highly specialised technologies guidance Remove Highly specialised technologies guidance filter
- Social care guidelines Remove Social care guidelines filter
- Public health guidelines Remove Public health guidelines filter
- Medical technologies guidance Remove Medical technologies guidance filter